Drug hypersensitivities: Definition, epidemiology and risk factors

European Annals of Allergy and Clinical Immunology

Volumn 37, Issue 6, 2005, Pages 202-206

  Demoly, P ^a   Rebelo Gomes, E ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b HOSPITAL MARIA PIA   (Portugal)

Author keywords

Drug allergy; Drug hypersensitivity; Incidence; Prevalence; Risk factors

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; AMOXICILLIN; AMPICILLIN; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CONTRAST MEDIUM; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PIPERACILLIN;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ATOPY; CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG FATALITY; DRUG HYPERSENSITIVITY; ETHNIC GROUP; GENETIC POLYMORPHISM; HOSPITALIZATION; HUMAN; INCIDENCE; MENINGOCOCCOSIS; META ANALYSIS; MORTALITY; OUTPATIENT; POPULATION RESEARCH; POPULATION RISK; PRESCRIPTION; PREVALENCE; PUBLIC HEALTH; RASH; REVIEW; RHEUMATIC FEVER; RISK FACTOR; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DRUG HYPERSENSITIVITY; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPTENS; HUMANS; INCIDENCE; MALE; META-ANALYSIS; OUTPATIENTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 22444448010     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Who. - International drug monitoring: the role of national centres. Tech Rep Ser WHO 1972, no 498.
2. Rawlins M.-D., Thompson J.-W. - Pathogenesis of adverse drug reactions. In; Davies DM, ed. Textbook of adverse drug reactions. Oxford: Oxford University Press 1977:10.
3. Johansson S., Bieber T, Dahl R., Friedmann P.-S., Lanier B.-Q., Lockey R.-F., Motala C., Ortega Martell J.-A., Platts-Mills T.-A., Ring J., Thien F., Van Cauwenberge P., Williams H.-C. - Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol., 2004;113:832-836.
4. Bates D.-W., Cullen D.-J., Laird N. et al. - Incidence of adverse drug events and potential adverse drug events. JAMA., 1995;274:29-34.
5. Lazarou J., Pomeranz B.-H., Corey P.-N. - Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA., 1998;279:1200-1205.
6. Olivier P., Boulbes O., Tubery M. et al. - Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department. Drug Saf., 2002;25:1035-1044.
7. Thong B.-Y., Leong K.-P., Tang C.-Y., Chng H.-H. - Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann. Allergy Asthma Immunol., 2003;90:342-347.
8. Mazzeo F., Capuano A., Avolio A., Filippelli A., Rossi F. - Hospital-based intensive monitoring of antibiotic-induced adverse events in a university hospital. Pharmacol. Res., 2005;51:269-274.
9. Kidon M.-I., See Y. - Adverse drug reactions in Singaporean children. Singapore Med. J., 2004;45:574-577.
10. Mertes P.-M., Laxenaire M.-C., Alla F. - Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology, 2003;99:536-545.
11. Katayama H., Yamaguchi K., Kozuka T. et al. - Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology, 1990;175:621-628.
12. International Rheumatic Fever Study Group. - Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet, 1991;337:1308-1310.
13. Apter A.-J., Kinman J.-L., Bilker W.-B. et al. - Represcription of penicillin after allergic-like events. J. Allergy Clin. Immunol., 2004;113:764-770.
14. Ibia E.-O., Schwartz R.-H., Wiedermann B.-L. - Antibiotic rashes in children: a survey in a private practice setting. Arch. Dermatol., 2000;136:849-854.
15. Burke P., Burne S.-R. - Allergy associated with ciprofloxacin. Br. Med. J., 2000;320:679.
16. Gomes E., Cardoso M.-F., Praça F. et al. - Self reported drug allergy in a general adult Portuguese population. Clin. Exp. Allergy, 2004;34:1597-1601.
17. Neugut A.-I., Ghatak A.-T., Miller R.-L. - Anaphylaxis in the United States: na investigation into epidemiology. Arch. Intern. Med., 2001;161:15-21.
18. Matasar M.-J., Neugut A.-I. - Epidemiology of anaphylaxis in The United States. Allergy Asthma Rep., 2003;3:30-35.
19. Pumphrey R. - Anaphylaxis: Can we tell who is at risk of a fatal reaction? Curr. Opin. Allergy Clin. Immunol., 2004; 4:285-290.
20. Helbling A., Hurni T., Mueller U.-R., Pichler W.-J. - Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940000 inhabitants of the Swiss canton Bern. Clin. Exp. Allergy, 2004;34:285-290.
21. Roujeau J.-C., Stern R.-S. - Severe cutaneous adverse reactions to drugs. N. Engl. J. Med., 1994;331:1272-1285.
22. Britschgi M., von Greyerz S., Burkhart C., Pichler W.-J. - Molecular aspects of drug recognition by specific T cells. Curr. Drug Targets, 2003;4:1-11.
23. Bigby M., Jick S., Jick H., Arndt K. - Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA, 1986;256:3358-3363.
24. De Week A.-L. - Pharmacologic and immunochemical mechanisms of drug hypersensitivity. Immunol. Allergy Clin. North Am., 1991;11:461-474.
25. Juan W.-H., Yang L.-C., Hong H.-S. - Acute generalized exanthematous pustulosis induced by topical lindane. Dermatology, 2004;209:239-240.
26. McIlwain M., Primosch R., Bimstein E. - Allergic reaction to intranasal midazolam HCL: a case report. Pediatr. Dent., 2004;26:359-361.
27. Barranco P., Lopez-Serrano M.-C. - General and epidemiological aspects of allergic drug reactions. Clin. Exp. Allergy, 1998;28:S61-62.
28. Haddi E., Charpin D., Tafforeau M., Kulling G., Lanteaume A., Kleisbauer J.-P., Vervloet D. - Atopy and systemic reactions to drugs. Allergy, 1990;45:236-239.
29. Asero R. - Detection of patients with multiple drug allergy syndrome by elective tolerance tests. Ann. Allergy Asthma Immunol., 1998;80:185-188.
30. Ponvert C., Le Clainche L., de Blic J. et al. - Allergy to β-lactam antibiotics in children. Pediatrics, 1999;104:954-955.
31. Sanchez-Borges M., Capriles-Hulett A. - Atopy is a risk for non steroidal anti inflammatory drug sensitivity. Ann. Allergy Asthma Immunol., 2000;84:101-106.
32. Fahrennholz J.-M. - Natural history and clinical features of aspirin-exacerbated respiratory disease. Clin. Rev. Allergy Immunol., 2003;24:113-124.
33. Coopman S.-A., Johnson R.-A., Platt R., Stern R.-S. - Cutaneous disease and drug reactions in HIV infection. N. Engl. J. Med., 1993;328:1670-1674.
34. Dykewicz M.-S. - Cough and angioedema from angiotensin converting enzyme inhibitors: new insights into mechanisms and management. Curr. Opin. Allergy Clin. Immunol., 2004;4:267-270.
35. Morimoto T., Gandhi T.-K., Fiskio J.-M. et al. - An evaluation of risk factors for adverse drug events associated with angiotensin converting enzyme inhibitors. J. Eval. Clin. Prac., 2004;10:499-509.
36. Brown N.-J., Ray W.-A., Snowden M., Griffin M.-R. - Black Americans have an increased rate of angiotensin converting enzyme inhibitor associated angioedema. Clin. Pharmacol. Ther., 1996;60:8-13.
37. Molinaro G., Cugno M., Perez M. et al. - Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. J. Pharmacol. Exp. Ther., 2002;303:232-237.
38. Martin A.-M., Nolan D., Gaudieri S. et al. - Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and haplotypic Hsp70-Hom variant. PNAS, 2004;101:4180-4185.
39. Pimohamed M., Lin K., Chadwick D., Park B.-K. - TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology, 2001;56:890-896.
40. Bavdekar S.-B., Muranjan M.-N., Gogtay N.-J. et al. - Anticonvulsant hypersensitivity syndrome:lyphocyte toxicity assay for the confirmation of diagnosis and risk assessment. Ann. Pharmacother., 2004;38:1648-1650.
41. Sanak M., Simon H.-U., Szczeklik A. - Leukotriene C4 synthase (LTC4s) promoter polymorphism and risk of aspirin-induced asthma. Lancet, 1997;350:1599-1600.
42. Qiao H.-L., Yang J., Zhang Y.-W. - Serum specific IgE levels and FcεRIβ genetic polymorphism in patients with penicillins allergy. Allergy, 2004;59:1326-1332.